The settlement and licensing agreement has increased the possibility of similar developments in the cases with other defendants. The stock has moved up strongly, and the volumes have been huge on certain days. The news flow has been driving the stock. The settlement and a licensing agreement ends all outstanding litigation with MyLikes and will improve the cash position of BCYP due to the royalty payments. The settlement indicates that the claims have substance, and increases the possibility of more settlement offers before the upcoming Markman hearings. Settlement is a good option to avoid the costly and time consuming litigation process, and it removes the uncertainty for all the parties. Some time ago, a SA article had estimated an upside of $0.5-$1 for the stock. In a report, Merriman Holdings had put a price target of $0.40 for the stock and upgraded it from Neutral to Speculative Buy. The recent developments indicate that it is surely a good bet, though the risks also have to be kept in mind. As per Merriam's report, the company has a strong set of patents, an emerging suite of software applications, some large pilot customers (including Ford), and a powerful litigation strategy playing out in the courts. It has received patents as “continuation” to the very important '516. The fact that the company has been able to obtain continuations also confirms the validity and substance of the patents. This increases the confidence about getting a positive outcome in the trials. Blue Calypso has also filed new CIPs which expand its inventions related to mobile / geo-enabled offers/coupons and rich media testimonials. The run-up to the Markman hearings may lead to more interest in the stock, so it is likely to remain active over the next few months. Any positive development in the hearing will only add to the positive momentum.